Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Grasping Various Kinds of Local misdemeanors - 2AfD faction in western Germany ousts councilman for firebrand speech
- 3the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
- 4Infants will no longer receive hepatitis B vaccine at birth, CDC announces
- 5The 25 Most Notable Style Crossroads in History
- The Specialty of Compromise: Examples from Reality
- The 15 Best Business visionaries Under 40
- Closets for Your Room: Plan and Utility Features
- Shas threatens to oppose 2026 state budget over haredi food-voucher exclusion
- Unwind: Four Extraordinary Spa Resorts On the planet
- Governors Ball 2026: Lorde, A$AP Rocky and Stray Kids set to headline
- 7 Fun Plans to Make Film Evenings Seriously Energizing (You'll Cherish #5!)
- Unwinding History's Secrets: Looking for the Response to Antiquated Human advancements
- Watch comet C/2026 A1 plunge toward the sun online this week
